MAXIMIZING INNOVATION

gene synthesis blockchain platform

MINIMIZING RISK

OUR GOAL IS TO DEVELOP INSTRUMENTS THAT GREATLY ENHANCE RESEARCH EFFORTS RELATED TO BIOLOGICAL DISCOVERY, DIAGNOSTICS, AND THERAPEUTICS

OVERVIEW

PRODUCT

PATHOGENS REPOSITORY

The Pathogens Repository component of the Biosecurity Platform manages a distributed database for pathogen-specific data that is built on top of a programmable blockchain (Ethereum) and distributed file system (IPFS). Key properties of the Pathogens Repository include transparency, immutability and capacity.

SCREENING PROTOCOL

The second component of the Biosecurity Platform is the Screening Protocol. This portion of the platform is used to define screening rules that can be directly evaluated against the Pathogens Repository. It is important that internationally coordinated regulators create a set of well-defined, designed and tested screening contracts which are publically available on the blockchain. The requirements defined by regulators will be critical to applications monitoring gene synthesis requests in the ecosystem.

PORTABLE GENE-SYNTHESIZING DEVICE

Our solution is a “cheap” (as compared to current world market of DNA synthesis devices) portable device that is designed to synthesize gene from an idea to a test-tube for extremely low price. Think of it as being a huge robotic-based extensive and very expensive equipment that has been condensed down to the size of a computer. Device is based on combination of oligonucleotide synthesizer and high-throughput gene assembly module. We are working hard on the system architecture with assumption that it will be mapped to microfluidic technologies in the future releases.

ADVANCED OPTIMIZATION STRATEGIES

TEAM

Aleksei Yantsevich

Co-founder, CEO

Dmitry Klevzhits

Co-founder, Сhairman

Vlad Omelyanchuk

Co-founder, Software Architect

Yaroslav Dichenko

Senior Researcher

ADVISORS

Arturo Bris

Scientific Advisor, Professor of Finance at IMD

Lars Wegner

Technology Advisor

Alex Shkor

Blockchain Advisor

Contact

Be the first to receive the latest SynTau news, events and product updates.

info@syntau.com

dmitry.klevzhits@syntau.com

+375 29 996-06-23